DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report)’s share price reached a new 52-week low during trading on Monday . The company traded as low as $106.85 and last traded at $106.85, with a volume of 30 shares. The stock had previously closed at $107.17.
Wall Street Analysts Forecast Growth
Separately, UBS Group downgraded DiaSorin from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 26th.
View Our Latest Report on DSRLF
DiaSorin Stock Performance
About DiaSorin
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
Featured Stories
- Five stocks we like better than DiaSorin
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Investing in the High PE Growth Stocks
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.
